Target intelligence / Profile preview

CLN8 antisense RNA 1 (CLN8-AS1)

Target
CLN8-AS1
Molecular classification
Long non-coding RNA (lncRNA), antisense RNA, non-coding natural antisense transcript (ncNAT)
01

Overview

CLN8 antisense RNA 1 (CLN8-AS1) is a long non-coding RNA located on the human genome antisense to the CLN8 gene. Antisense RNAs typically function in the regulation of their sense gene counterparts through transcriptional interference, chromatin modification, and modulation of gene expression. While CLN8 mutations are associated with neuronal ceroid lipofuscinosis, the functional role of CLN8-AS1 in health or disease has not been directly characterized. No drugs or clinical biomarkers are known to target or utilize CLN8-AS1, and it is not a canonical drug target such as a receptor or enzyme.

Other names
CTD-2336O2.1CLN8-AS1
02

Mechanism of action

None documented (as CLN8-AS1 is not a canonical therapeutic target; antisense RNAs typically regulate target mRNA via transcriptional interference or chromatin remodeling, but no specific mechanisms described for CLN8-AS1)

03

Biological functions

Regulation of gene expression (primarily at CLN8 locus)transcriptional interferenceinvolvement in chromatin modificationpotential role in epigenetic regulation
04

Disease associations

Other (potentially relevant in neurodegenerative disease through regulation of CLN8, but specific disease associations for CLN8-AS1 are not established)

Beyond the preview

Go deeper on CLN8 antisense RNA 1 (CLN8-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CLN8 antisense RNA 1 (CLN8-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call